European Commission (EC)
338 articles about European Commission (EC)
-
Oncurious Release: Company Announces European Commission (EC) Confirmed Orphan Medicinal Product Designation For TB-403 For Medulloblastoma
1/17/2017
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Vemlidy (Tenofovir Alafenamide, TAF) For The Treatment Of Chronic Hepatitis B Virus Infection
1/11/2017
-
PTC Therapeutics Release: European Commission (EC) Ratifies Positive CHMP Opinion For The Renewal Of Translarna Marketing Authorization For The Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy
1/10/2017
-
Advanced Accelerator Applications Announces European Commission (EC) Approval Of SomaKit TOC
12/15/2016
-
European Commission (EC) Grants Intercept Pharma’s Ocaliva (Obeticholic Acid) Marketing Authorization For The Treatment Of Primary Biliary Cholangiti
12/14/2016
-
Takeda Pharmaceutical Co. Ltd. Release: NINLARO (Ixazomib) Receives Conditional Approval From The European Commission (EC) To Treat Multiple Myeloma
11/28/2016
-
European Commission (EC) Approves Bristol-Myers Squibb's Opdivo(Nivolumab) For The Treatment Of Adult Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant And Treatment With Brentuximab Vedotin
11/23/2016
-
Janssen Pharmaceutical Companies Release: Phase 3 Study Results Supporting U.S. FDA And European Commission (EC) Approvals Of STELARA In The Treatment Of Moderately To Severely Active Crohn's Disease Published In The New England Journal of Medicine
11/17/2016
-
Amgen Release: European Commission (EC) Approves Parsabiv (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis
11/14/2016
-
Janssen-Cilag International NV Release: European Commission (EC) Approves STELARA (Ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn’s Disease
11/11/2016
-
Swedish Orphan Biovitrum: European Commission (EC) Grants SOBI003 Orphan Designation For The Treatment Of MPS IIIA
10/19/2016
-
SkylineDx And Consortium Of Leading European Partners Awarded Multi-Million Euro Horizon2020 Grant From European Commission (EC)
10/4/2016
-
European Commission (EC) Approves Transfer Of Marketing Authorisation For Alprolix Sobi
10/3/2016
-
European Commission (EC) Approves Ipsen’s Cabometyx (Cabozantinib) Tablets For The Treatment Of Advanced Renal Cell Carcinoma (RCC) In Adults Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy
9/14/2016
-
MeMed Diagnostics Release: €2.3 Million Award By European Commission (EC) Will Support Deployment Of Immunoxpert To Reduce Antibiotic Misuse In Hospitals
9/8/2016
-
European Commission (EC) Approves Bristol-Myers Squibb’s ORENCIA (Abatacept) For The Treatment Of Highly Active And Progressive Disease In Adult Patients With Rheumatoid Arthritis Not Previously Treated With Methotrexate
9/6/2016
-
Alexion Release: European Commission (EC) Grants Orphan Drug Designation To ALXN1007 For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD)
8/30/2016
-
European Commission (EC) Grants Marketing Authorization For Gilead’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1
8/22/2016
-
European Commission (EC) Grants Marketing Authorization For Teva’s CINQAERO (Reslizumab)
8/18/2016
-
Merck & Co.’s KEYTRUDA (Pembrolizumab) Approved By The European Commission (EC) For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
8/3/2016